Results 271 to 280 of about 340,370 (339)

Beyond Familial Hypercholesterolemia: Your Feet can Help Predict Your Coronary Atherosclerosis. [PDF]

J Atheroscler Thromb
Kawashiri MA, Tada H.
europepmc   +1 more source

Polyphasic Characterization of Acetobacter indonesiensis UNPADCC 01‐5 Isolated From a Traditional Fermented Food, Oncom Merah

Environmental Microbiology Reports, Volume 18, Issue 3, June 2026.
The polyphasic approach (morphology, physiology, biochemistry and genetics) was used to characterize Acetobacter indonesiensis strain UNPADCC 01‐5, which was isolated from oncom merah. The strain's potential as a culture for acidic fermentations and a biofunctional agent was supported by its adaptive characteristics, which included acid tolerance ...
Yolani Syaputri, Erisa Zahra, Rianti Nur Azzahra, Annisa, Diffa Amanda Iswhara, Felice Olivia Lengkey, Syiffa Fauzia, Xiwu Jia, Asri Peni Wulandari, Ratu Safitri   +9 more
wiley   +1 more source

Characterization of selected LDLR substitutions in patients with familial hypercholesterolemia. [PDF]

Atheroscler Plus
Targońska M, Janaszak-Jasiecka A, Chmara M, Żuk M, Kalinowski L, Waleron K, Jasiecki J, Wasąg B.   +7 more
europepmc   +1 more source

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 333-350, June 2026.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown, Graham Meredith, Bo Gao, Pei Ding, Harriet Gee, Inês Pires da Silva, Adnan Nagrial, Eric Hau   +7 more
wiley   +1 more source

Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness Study.

JAMA
Bellows BK, Zhang Y, Ruiz-Negrón N, Kazi DS, Khera AV, Woo JG, Urbina EM, Jacobs DR, Allen NB, Wong JB, de Ferranti SD, Moran AE.   +11 more
europepmc   +1 more source

First LDLRAP1 and Recurrent LDLR Mutations in Tunisian Families With Familial Hypercholesterolemia. [PDF]

J Cell Mol Med
Ncir WB, Ben-Mahmoud A, Frikha H, Abdelhedi F, Kacem FH, Majdoub N, Mnif M, Kim HG, Keskes LA, Hottenga JJ.   +9 more
europepmc   +1 more source

Maternal Dyslipidaemia Aggravates Offspring Metabolic Dysfunction–Associated Steatotic Liver Disease

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 6, June 2026.
ABSTRACT Paediatric metabolic dysfunction–associated steatotic liver disease (MASLD) and steatohepatitis (MASH) display a distinct and severe histopathology. Maternal metabolic status may program offspring susceptibility to MASLD. This study investigated if maternal dyslipidaemia and low vitamin C (VitC) status influence offspring MASLD using a ...
Kamilla Pedersen, Sanne Fredslund Buhl, Cecilie Højgaard‐Jensen, Jens Lykkesfeldt, Pernille Tveden‐Nyborg   +4 more
wiley   +1 more source

Metformin Ameliorates Cognitive Deficits and Neuroinflammation in a Mouse Model of Familial Hypercholesterolemia. [PDF]

Neurochem Res
do Nascimento NB, Farias HR, Schons T, Padilha APZ, Costa MV, Peres AM, da Silva LDS, Dantas RM, Ramos JMO, Rodrigues MS, Telles F, Guma FTCR, Moreira JCF, Bast RKSS, de Bem AF, de Oliveira J.   +15 more
europepmc   +1 more source

Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4991-5000, June 2026.
ABSTRACT Aims Type 2 diabetes mellitus (T2DM) has been inversely associated with prostate cancer (PrCa) risk. However, it remains unclear whether a polygenic risk score (PRS) for PrCa can effectively stratify risk among men with T2DM. The primary objective of this study was to assess whether a PrCa PRS predicts PrCa risk independently of T2DM status ...
Guk Jin Lee, Sang‐Hyuk Jung, Jonghyun Lee, Ki Won Moon, Penn Medicine Biobank, Daniel J. Rader, Marylyn D. Ritchie, JoEllen Weaver, Nawar Naseer, Giorgio Sirugo, Afiya Poindexter, Yi‐An Ko, Kyle P. Nerz, Meghan Livingstone, Fred Vadivieso, Stephanie DerOhannessian, Teo Tran, Julia Stephanowski, Salma Santos, Ned Haubein, Joseph Dunn, Colleen Morse Kripke, Marjorie Risman, Renae Judy, Colin Wollack, Anurag Verma, Shefali S. Verma, Scott Damrauer, Yuki Bradford, Scott Dudek, Theodore Drivas, Jae‐Seung Yun, Dokyoon Kim   +32 more
wiley   +1 more source

Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

Hepatology Research, Volume 56, Issue 6, Page 887-902, June 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, with an increasing number of patients progressing to cirrhosis and hepatocellular carcinoma (HCC). Early identification of individuals at high risk for advanced fibrosis is essential for preventing liver‐related ...
Norio Akuta, Tomomi Kogiso, Kenichi Ikejima, Motoyuki Otsuka, Takumi Kawaguchi, Miwa Kawanaka, Hirokazu Takahashi, Nobuharu Tamaki, Hayato Nakagawa, Hayato Hikita, Hideki Fujii, Kanji Yamaguchi, Masato Yoneda, Kazuyoshi Kon, Akira Uchiyama, Yuya Seko, Sadatsugu Sakane, Ryuta Shigefuku, Naoto Fujiwara, Michihiro Iwaki, Takashi Kobayashi, Takuya Adachi, Yasuto Takeuchi, Tsubasa Tsutsumi, Dan Nakano, Kaoru Shibayama, Noriyo Urata, Hisamitsu Miyaaki, Hidekatsu Kuroda, Masahiro Koseki, Hirohito Sone, Yasuhiro Matsubayashi, Keisuke Kakisaka, Atsushi Takai, Kazuo Notsumata, Masataka Seike, Yoshiyuki Takei, Yoshifumi Takeyama, Susumu Eguchi, Sumio Watanabe, Hajime Isomoto, Hiroshi Yotsuyanagi, Takao Itoi, Tetsuo Takehara, Satoshi Mochida   +44 more
wiley   +1 more source